Xspray Pharma AB (publ) filed its Annual on Mar 29, 2023 for the period ending Dec 31, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
72.8 SEK | -3.45% | +24.57% | +82.50% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.50% | 197M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-0.96% | 21.83B | |
-11.18% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- XSPRAY Stock
- News Xspray Pharma AB
- Xspray Pharma AB Auditor Raises 'Going Concern' Doubt